Kavli Affiliate: Li Zhao | Authors: Li Na Zhao and Jesper Andersen | Summary: Background The rising burden of metabolic dysfunction-associated steatotic liver disease (MASLD)-associated hepatocellular carcinoma (HCC) underscores the need for innovative therapeutic strategies. Methods We integrated RNA-seq fusion detection, immunopeptidomics, and proteogenomics to systematically prioritize tumor-specific neoantigen candidates arising from gene fusions in MASLD-HCC. Results We […]
Continue.. Fusion-derived phospho-neoepitopes define a prioritized candidate neoantigen repertoire in MASLD-HCC